Technical Analysis for INO - Inovio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 16.94 10.21% 1.57
INO closed up 10.21 percent on Friday, September 25, 2020, on 61 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
116 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical INO trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Calm After Storm Range Contraction 10.21%
NR7 Range Contraction 10.21%
NR7-2 Range Contraction 10.21%
Wide Bands Range Expansion 10.21%
Overbought Stochastic Strength 10.21%
Older End-of-Day Gignals for INO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 10% about 15 hours ago
60 Minute Opening Range Breakout about 15 hours ago
Rose Above 50 DMA about 16 hours ago
10 DMA Support about 17 hours ago
50 DMA Resistance about 17 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. The company's DNA-based SynCon technology enables the design of vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Its electroporation DNA delivery technology uses controlled electrical pulses to enhance cellular DNA vaccine uptake. The company's clinical programs include human papillomavirus/cervical cancer (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus, hepatitis B virus, human immunodeficiency virus, and malaria vaccines. It is also advancing preclinical research for a seasonal/pandemic influenza vaccine, as well as other products. Inovio Pharmaceuticals, Inc. has collaboration and license agreements with VGX International, Merck, and ChronTech. The company was formerly known as Inovio Biomedical Corporation and changed its name to Inovio Pharmaceuticals, Inc. in May 2010. Inovio Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Blue Bell, Pennsylvania.
Medicine Infectious Diseases Cancers Prostate Cancer Coronavirus Vaccine Influenza Vaccination Leukemia Virus Virology Influenza Vaccine Malaria Seasonal/Pandemic Influenza Universal Flu Vaccine

Is INO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 33.79
52 Week Low 1.915
Average Volume 21,930,493
200-Day Moving Average 11.41
50-Day Moving Average 16.39
20-Day Moving Average 13.20
10-Day Moving Average 15.91
Average True Range 1.99
ADX 30.38
+DI 28.12
-DI 18.04
Chandelier Exit (Long, 3 ATRs ) 12.72
Chandelier Exit (Short, 3 ATRs ) 14.75
Upper Bollinger Band 19.45
Lower Bollinger Band 6.95
Percent B (%b) 0.8
BandWidth 94.70
MACD Line 0.50
MACD Signal Line -0.21
MACD Histogram 0.7175
Fundamentals Value
Market Cap 1.53 Billion
Num Shares 90.2 Million
EPS -1.07
Price-to-Earnings (P/E) Ratio -15.83
Price-to-Sales 9.78
Price-to-Book 3.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.61
Resistance 3 (R3) 18.43 17.69 18.33
Resistance 2 (R2) 17.69 17.27 17.78 18.23
Resistance 1 (R1) 17.32 17.01 17.51 17.50 18.14
Pivot Point 16.58 16.58 16.68 16.67 16.58
Support 1 (S1) 16.21 16.16 16.40 16.39 15.74
Support 2 (S2) 15.47 15.90 15.56 15.65
Support 3 (S3) 15.10 15.47 15.55
Support 4 (S4) 15.28